Ettevõte | Roll | Seos alates | Müügitulu |
---|---|---|---|
SOLIS US INVEST OÜ | 04.11.2009 | 3,24 mln € (2023) | |
SOLIS BIODYNE OÜ | 26.10.2018 | 3,24 mln € (2023) | |
SERADES OÜ | 11.06.2010 | 8 350 € (2023) | |
NORTRAST OÜ | 27.10.2018 | ||
NOBISOL TECHNOLOGIES OÜ | 11.06.2010 | 0 € (2023) | |
NOVOTAR BIOTECH OÜ | 11.06.2010 | 0 € (2023) | |
CELLANDRO INVESTMENTS OÜ | 10.06.2021 | 13 733 € (2023) | |
SBD CAPITAL OÜ | 04.06.2021 | 723 € (2023) | |
LAND EXCHANGE OÜ | 02.09.2023 | 29 046 € (2022) |
Ettevõte | Protsent | Osalus | Müügitulu |
---|---|---|---|
SOLIS US INVEST OÜ | 4 000 € | 3,24 mln € (2023) | |
SERADES OÜ | 2 556 € | 8 350 € (2023) | |
NORTRAST OÜ | 2 600 € | ||
NOVOTAR BIOTECH OÜ | 959 € | 0 € (2023) | |
LAND EXCHANGE OÜ | 317 € | 29 046 € (2022) |
Ettevõte | Kontrolli teostamise viis | Müügitulu |
---|---|---|
SOLIS US INVEST OÜ | - | 3,24 mln € (2023) |
SOLIS BIODYNE OÜ | - | 3,24 mln € (2023) |
SERADES OÜ | - | 8 350 € (2023) |
NORTRAST OÜ | - | |
NOBISOL TECHNOLOGIES OÜ | - | 0 € (2023) |
NOVOTAR BIOTECH OÜ | - | 0 € (2023) |
CELLANDRO INVESTMENTS OÜ | - | 13 733 € (2023) |
SBD CAPITAL OÜ | - | 723 € (2023) |